Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST

Tenaya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-120.74-124.08-123.67-72.72-38.4-26.23
Depreciation & Amortization
8.648.696.472.962.481.99
Loss (Gain) From Sale of Assets
----0.030.01
Loss (Gain) From Sale of Investments
1.440.32-0.310.13--0.1
Stock-Based Compensation
16.815.3111.472.950.740.41
Other Operating Activities
3.493.352.461.13-0.080.06
Change in Accounts Payable
-4.22-3.281.668.60.140.4
Change in Other Net Operating Assets
-3.25-2.37-2.51-3.86-0.38-0.65
Operating Cash Flow
-97.84-102.07-104.42-60.81-35.45-24.1
Capital Expenditures
-1.04-1.24-20.63-25.12-9.76-2.93
Investment in Securities
33.7549.98104.27-213.442.75-2.66
Other Investing Activities
-0.02-0.030.01---
Investing Cash Flow
32.748.7283.65-238.56-7.01-5.58
Issuance of Common Stock
47.714.5577.771890.030.07
Repurchase of Common Stock
----0.01-0-0
Other Financing Activities
--0.5----
Financing Cash Flow
47.714.0577.77208.97147.2730.51
Net Cash Flow
-17.43-49.3157-90.41104.810.83
Free Cash Flow
-98.88-103.31-125.05-85.93-45.21-27.02
Free Cash Flow Per Share
-1.25-1.40-2.79-4.85-46.51-35.75
Levered Free Cash Flow
-58.39-60.78-83.92-52.6-30.25-
Unlevered Free Cash Flow
-58.39-60.78-83.92-52.6-30.25-
Change in Net Working Capital
3.451.542.71-12.11-0.61-
Source: S&P Capital IQ. Standard template. Financial Sources.